MaxCyte Hosts Live Discussion with Industry Experts on the Challenges in Developing Cell-Based Screening Assays for Drug... ( GAITHERSBURG Md. Nov. 12 -- MaxC...)

HOME >> BIOLOGY >> TECHNOLOGY

MaxCyte Hosts Live Discussion with Industry Experts on the Challenges in Developing Cell-Based Screening Assays for Drug Discovery

Date:11/12/2008

GAITHERSBURG, Md., Nov. 12 /PRNewswire-USNewswire/ -- MaxCyte, Inc., the pioneer in scalable, high performance cell loading systems, announces that it will be hosting a live discussion with industry experts on the challenges in developing cell-based screening assays for drug discovery. The discussion is open to the industry and will be held by webinar on Thursday, November 13th from 2:00-3:00EST.

One of the respected industry experts leading this live discussion is Dr. John Reardon, formerly Senior Vice President of Discovery Research Biology at GSK and now Executive Vice President and Chief Scientific Officer at Integrated Oncology Solutions Inc (IOS) in North Carolina. Dr. Reardon will review the complexities of cell transfection technologies and challenge the webinar participants to consider the possibilities of creating more relevant assays if it were possible to transfect any molecule into any cell at any scale, while maintaining biological integrity and the high quality standards. His discussion will offer compelling arguments as to how the MaxCyte(R) STX System can reduce bottlenecks and improve the productivity of drug discovery groups.

Dr. James Brady, Director Technical Applications, will lead the webinar participants through a technical presentation of the MaxCyte(R) STX System. Dr. Brady will demonstrate how the MaxCyte STX technology enables the large scale transfection of primary cells, cell lines, and stem cells with multiple loading agents at the same time, resulting in more relevant screening systems.

According to MaxCyte CEO Doug Doerfler, "We are delighted to have the enthusiastic validation for our technology from such a renowned industry expert as Dr. Reardon. The MaxCyte STX is being viewed by the pharmaceutical industry as an enabling technology for cell modification for both research and larger scale cell-based applications in drug discovery. The MaxCyte STX can produce a large number of transfected cells in minute
'/>"/>

SOURCE MaxCyte, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2
Related biology technology :

1. Medinet Licenses MaxCyte Cell Loading Technology for Cancer Immunotherapy in Japan
2. Binex and MaxCyte Collaborate on Cancer Immunotherapy Research
3. MaxCyte to Present at BIO-Europe Spring 2008 Conference
4. MaxCyte Debuts the STX Scalable Transfection System at the A/C/T Assays & Cellular Targets Meeting
5. MaxCyte and Medinet to Present at the 10th International Symposium on Dendritic Cells in Kobe, Japan
6. The MaxCyte STX Scalable Transfection System to be Launched at the SBS Symposium on Cell-Based Assays
7. Luminex Corporation Hosts the Fifth Annual Planet xMAP Europe 2007 Symposium
8. Pharsight Hosts Fourth Annual PKS User Group Meeting
9. Germany Hosts World Leading Medical Industry Fair
10. Cell Therapeutics, Inc. (CTI) Hosts Conference Call to Discuss Update on Zevalin(R) Acquisition, CMS Reimbursement, and PIX301 Timeline
11. DuoCort Hosts Adrenal Insufficiency Symposium at the 10th European Congress of Endocrinology in Berlin

Post Your Comments:

(Date:5/23/2013)... May 23, 2013 Graphite Metallizing ... self-lubricating bushings mounted in stainless steel pillow blocks. ... of GRAPHALLOY with the application and installation versatility ... Pillow Blocks work exceptionally well when submerged ... hostile liquids such as acids, alkalies, hydrocarbons, black ...

(Date:5/23/2013)... May 23, 2013 PI’s new ... and provide 15 mm travel range with closed-loop ... small dimensions make these new positioners the ideal ... A vacuum rated version is also available. ... and datasheets can be found at: , ...

(Date:5/23/2013)... On April 19th the Center ... search for the growing antibiotic resistant bacteria that may ... year long study were released late last month showing ... over previous years. For those suffering from bacteria driven ... resistant bacteria in food, may eventually help breed acne ...

(Date:5/23/2013)... 2013 Verenium Corporation (Nasdaq: VRNM ), ... and commercialization of high-performance enzymes, today announced that ... present at two upcoming conferences. (Logo: ... the Second Annual Marcum LLP Microcap Conference on Thursday, ... New York City. The presentation is scheduled to begin ...

Breaking Biology Technology:Graphite Metallizing Now Offers GRAPHALLOY® Stainless Steel Pillow Blocks for Success in Submersible Applications 2 Graphite Metallizing Now Offers GRAPHALLOY® Stainless Steel Pillow Blocks for Success in Submersible Applications 3 Precision Positioning System Uses Miniaturezed Piezo Linear Motor: LPS-24 Linear Stage by PI 2 Acne Cream, Probiotic Action Shares News on How Some Food may Breed Acne Causing Bacteria 2 Verenium To Present At Two Upcoming Conferences 2 Verenium To Present At Two Upcoming Conferences 3

[0] Graphite Metallizing Now Offers GRAPHALLOY® Stainless Steel Pillow Blocks for Success in Submersible Applications [0] Precision Positioning System Uses Miniaturezed Piezo Linear Motor: LPS-24 Linear Stage by PI [0] Acne Cream, Probiotic Action Shares News on How Some Food may Breed Acne Causing Bacteria [0] Verenium To Present At Two Upcoming Conferences

... N.J., July 21 BioNeutral Group, Inc. ("BioNeutral") (OTC ... Science Company announced today that at ATS Labs using ... Antimicrobial passed the difficult Quantitative Disk Carrier test ... difficile (C.diff) present in this test ...

... , , PALO ALTO, Calif., July 21, ... third quarter of its fiscal year 2009 after 1:00 p.m. Pacific Time ... of its investor conference call to review those quarterly results is scheduled ... , That live webcast can be accessed from Varian, ...

... , , KENILWORTH, N.J., July 21 ... for the 2009 second quarter. , , ... given us the strength to again power through tough challenges - delivering ... Fred Hassan, chairman and CEO. , , ...

BioNeutral's Ygiene(TM) Hospital Grade Achieves a 100% Total Kill (Pass) Against the Life Threatening Clostridium Difficile (C.diff) Spores in Independent EPA Required Protocol Testing.Varian, Inc. to Webcast Conference Call on Third Quarter Fiscal Year 2009 Financial Results Schering-Plough Reports Financial Results for 2009 Second Quarter

(Date:5/22/2013)... National Lung Screening Trial (NLST) investigators also conclude ... mortality with low-dose computed tomography (LDCT) versus chest ... primary paper is achievable at experienced screening centers ... more information to share with their patients about ... screening following today,s publication in the New ...

(Date:5/22/2013)... 2013)The omega 3 fatty acids in fish oil have ... so that the American Heart Association currently recommends eating ... fatty varieties rich in omega 3s. However, the mechanism ... a new study, scientists led by Jason R. Carter ... by providing evidence that fish oil might specifically counteract ...

(Date:5/22/2013)... Legionella pneumophila bacteria is responsible for legionellosis, an ... to infect us, this pathogen has developed a complex ... in our cells, thus avoiding these acting against the ... research centre, CIC bioGUNE, in which teams from the ... the National Supercomputation Centre in Barcelona (BSC) have also ...

Breaking Biology News(10 mins):NLST: CT detects twice as many lung cancers as X-ray at initial screening exam 2 NLST: CT detects twice as many lung cancers as X-ray at initial screening exam 3 Fish oil may help the heart beat mental stress 2 Mechanism discovered which aids Legionella to camouflage itself in the organism 2

[0] NLST: CT detects twice as many lung cancers as X-ray at initial screening exam [1] Fish oil may help the heart beat mental stress [0] Mechanism discovered which aids Legionella to camouflage itself in the organism

... This press release is available in French ... kind, combines two complementary analytical brain imaging techniques, to provide ... the autistic brain. The study, published in the April issue ... by researchers at The Montreal Neurological Institute and Hospital ...

... It,s illegal for health products with medical formulations to be ... on animals ― a situation that has serious ethical and ... by Prof. Amit Gefen of Tel Aviv University,s Faculty of ... be needed for the necessary experimental trials. Dr. Gefen,s ...

... The six sponsoring societies for the meeting ... The American Physiological Society, American Society for Biochemistry ... American Society for Nutrition, and American Society for ... some of the science being presented April 24-28, ...

Cached Biology News:Dual approach gives a more accurate picture of the autistic brain 2 Dual approach gives a more accurate picture of the autistic brain 3 A lab rat -- created in the lab 2 Selected highlights of the research being presented at the Experimental Biology 2010 meeting 2 Selected highlights of the research being presented at the Experimental Biology 2010 meeting 3 Selected highlights of the research being presented at the Experimental Biology 2010 meeting 4

Dual approach gives a more accurate picture of the autistic brain A lab rat -- created in the lab Selected highlights of the research being presented at the Experimental Biology 2010 meeting

This antibody detects cdc42 on SDS-PAGE immunoblots....

Goat polyclonal to Nebraska Calf Diarrhea Virus (FITC) ( Abpromise for all tested applications). Antigen: Bovine (Nebraska Calf Diarrhea Virus)....

DNA fragmentation factor & Inhibitor of CAD...

Rabbit polyclonal to Methionine Aminopeptidase 2 ( Abpromise for all tested applications). entrezGeneID: 10988 SwissProtID: P50579...

Biology Products:

Rabbit Anti-cdc42 / Rac Polyclonal Antibody, Unconjugated from Assay Designs/Stressgen Bioreagents Goat Anti-Human Nebraska Calf Diarrhea Virus Polyclonal Antibody, FITC Conjugated from Abcam Anti-Human DFF45 / ICAD (NT) Polyclonal Antibody, Unconjugated from Cell Sciences Rabbit Anti-Methionine Aminopeptidase 2 Polyclonal Antibody, Unconjugated from Abcam